Eduard Folch Rue - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Roche’s experimental once-weekly obesity and diabetes drug enicepatide delivered 15.5% average weight loss and strong HbA1c reductions in a Phase II trial, strengthening its challenge in the fast-growing weight-loss drug market. Representative image.

Roche’s enicepatide delivers 15.5% weight loss in type 2 diabetes Phase II trial

Mercedes-Benz signs production deal for Wayve AI Driver launch within two years

Iran and US open diplomatic channel as Pezeshkian links Hormuz reopening to end of pressure

Alibaba unveils Zhenwu V900 chip and targets 20GW of AI cloud capacity

Read More

General business news

SulAmérica to divest auto and other property-casualty operations to Allianz

Allianz, a German multinational financial services company, has entered into an agreement with Brazilian insurance company SulAmérica to…

byRaghuram Kadari

August 26, 2019

web analytics